Provided by Tiger Trade Technology Pte. Ltd.

Nasdaq

90.33
-1.3400-1.46%
Post-market: 90.400.0700+0.08%19:59 EDT
Volume:3.37M
Turnover:304.54M
Market Cap:50.49B
PE:26.34
High:92.27
Open:92.18
Low:89.67
Close:91.67
52wk High:101.79
52wk Low:76.55
Shares:559.00M
Float Shares:496.00M
Volume Ratio:1.05
T/O Rate:0.68%
Dividend:1.12
Dividend Rate:1.24%
EPS(TTM):3.43
EPS(LYR):3.09
ROE:16.52%
ROA:5.85%
PB:4.21
PE(LYR):29.23

Loading ...

ECGI Holdings Signs LOI to Acquire Avanta Group in Series V Preferred Stock Deal

Reuters
·
Sep 28

Silexion Says Sil204 Uses Native Serum Lipids for Cellular Uptake, Boosts KRAS Knockdown in Preclinical Study

Reuters
·
Sep 28

Carlsmed Names Richard Heppenstall CFO, Succeeding Leo Greenstein

Reuters
·
Sep 28

DLH Wins NIH Cybersecurity Operations Task Order Worth up to $19.1 Million

Reuters
·
Sep 28

Virtualware Completes Virtalis Acquisition for EUR 5 Million Upfront

Reuters
·
Sep 28

Latin Metals Corrects June 29 Release on 400,000 Stock Option Grants to Consultants

Reuters
·
Sep 28

Alaris Equity Partners Closes CAD 115.02 Million Bought-Deal Unit Offering at CAD 22.40 Each

Reuters
·
Sep 28

Daré Bioscience Wins New US Patent Covering Topical Lopinavir-Ritonavir Formulation for DARE-HPV Program

Reuters
·
Sep 28

Borregaard Secures NOK 1.5 Billion Sustainability-Linked Revolving Credit Facilities Refinancing

Reuters
·
Sep 28

Foresight Autonomous Signs Term Sheet to Buy 50.01% Stake in Polish Data Center Developer

Reuters
·
Sep 28

Comstock Resources, SOCAR Sign Framework Agreement for $1.65 Billion Haynesville Shale Partnership

Reuters
·
Sep 28

Phillips Edison Schedules Third-Quarter Earnings Conference Call

Reuters
·
Sep 28

4D Molecular Therapeutics Enrolls First Patients in Phase 3 4sight Trial of 4D-150 for Diabetic Macular Edema

Reuters
·
Sep 28

Fobi AI Shifts Focus to Flywheel Product Stack, Targets Legacy Business Transition by End-2026

Reuters
·
Sep 28

Harvard Ave Acquisition Agrees to Merge with Pipeline Services Provider OAG International

Reuters
·
Sep 28

ALX Oncology Says Phase 2 ASPEN-06 Study Shows 40.3% Response Rate for Evorpacept Combo in HER2-Positive Gastric Cancer

Reuters
·
Sep 28

Allarity Therapeutics Expands In-House Lab to Add Proteomics, Cell Line Research

Reuters
·
Sep 28

Lantheus Doses First Patient in Sparrow Phase 2/3 Prostate Cancer Imaging Trial for LNTH-2401

Reuters
·
Sep 28

Humacyte Adds Scott Coward to Board, Names Him to Audit Committee

Reuters
·
Sep 28

ReconAfrica Resumes Work at Namibia KW1X as Horizontal Drilling Nears

Reuters
·
Sep 28